News
"In October We Wear Pink" Hoodie - Breast Cancer Awareness Sweatshirt With Angel Wings, Support Survivor
38+ min ago (273+ words) In October We Wear Pink Sweatshirt Pink Angel Wings Shirt Support Survivor Hoodie Women Breast Cancer Awareness Shirt This In October We Wear Pink Sweatshirt honors breast cancer awareness with a beautiful pink angel wings design, symbolizing hope and support…...
When should you get a mammogram?
1+ day, 36+ min ago (969+ words) AP A radiologist uses a magnifying glass to examine mammograms for breast cancer in Los Angeles, May 6, 2010. WASHINGTON " Deciding when to get routine mammograms is confusing. Some health groups recommend women begin at age 40 or 45 while another recently opted for…...
Breast Cancer Support Services Welcomes Two New Staff Members
1+ hour, 4+ min ago (327+ words) From Breast Cancer Support Services of Berks County Pictured above, from left to right: Karin Allmendinger and Katia Botelho. Breast Cancer Support Services of Berks County (BCSS) is pleased to announce that Karin Allmendinger and Katia Botelho have joined the…...
Roche unveils promising breast cancer treatment. .. | Pluang " Crypto, Stocks, Gold & Funds
5+ hour, 50+ min ago (243+ words) At ASCO 2026, Roche presented new data on nine cancer medicines, with a focus on giredestrant for ER-positive, HER2-negative breast cancer. Key trials showed giredestrant's potential to become a new standard of care by reducing recurrence risk and improving progression-free survival…...
FGFR1, Not S6 K1/2, Fuels BRAF Resistance
1+ hour, 36+ min ago (759+ words) In a groundbreaking study poised to reshape the landscape of melanoma treatment, researchers have pinpointed a key molecular pathway responsible for intrinsic resistance to BRAF inhibitors'one of the frontline therapies against this formidable skin cancer. The investigation, led by Almoiliqy,…...
ELUT: Antibiotic-eluting matrix targets high breast reconstruction infection rates in a $1. 5 B market
14+ hour, 7+ min ago (75+ words) Trading View ELUT: Antibiotic-eluting matrix targets high breast reconstruction infection rates in a $1. 5 B market A proven antibiotic-eluting matrix platform is being adapted for breast reconstruction, targeting a $1. 5 billion U. S. market with high infection rates. FDA approvals are expected within a…...
Predictors of Pathological Complete Response and Patient-Reported Outcomes During Neoadjuvant Chemotherapy in Early Breast Cancer: A Single-Center Retrospective Cohort Study
3+ hour, 2+ min ago (227+ words) Background: Neoadjuvant chemotherapy (NAC) is the standard of care for biologically aggressive early breast cancer, and pathological complete response (p CR) is a robust surrogate of long-term outcome. Real-world cohorts integrating clinical, pathological, and patient-reported variables remain limited. Methods: We…...
FDA Expands Enhertu Approval for Early-Stage HER2-Positive Breast Cancer
2+ hour, 48+ min ago (355+ words) The FDA has approved two new indications for trastuzumab deruxtecan (Enhertu) in patients with early-stage HER2-positive breast cancer. One approval covers neoadjuvant treatment for stage II'III disease, using Enhertu followed by a regimen of taxane, trastuzumab (Herceptin), and pertuzumab (Perjeta)…...
Researchers Warn Adult Obesity Could Trigger Multiple Cancers | THE DAILY TRIBUNE | KINGDOM OF BAHRAIN
3+ hour, 10+ min ago (198+ words) Researchers Warn Adult Obesity Could Trigger Multiple Cancers News of Bahrain Email: online@newsofbahrain. com Stockholm: According to recent research presented at the European Congress on Obesity, adults who gain significant weight later in life may have a significantly increased…...
When should women start getting mammograms? " and more UCLA media
5+ hour, 39+ min ago (334+ words) More highlights from UCLA in the News: May 18, 2026 The rapid spread demands a rapid response, says Anne Rimoin, an epidemiologist at the University of California, Los Angeles, who has worked on disease outbreaks in the [Democratic Republic of the Congo]…...